Kiadis Pharma is proud to be supported by a group of knowledgeable investors, contributing their expertise and network to enhance the development opportunities of the company.
LSP is a leading independent European biotech focused venture capital firm, providing private equity financing to early to mid stage life science companies. Since the late 1980s, LSP’s management has invested in a large number of highly innovative enterprises, many of which have grown to become leaders of the global life-science industry. With EUR 450 million under management and offices in Amsterdam, Munich and Boston, LSP is one of Europe’s largest and most experienced specialist life-science investors.
Alta invests in life sciences companies across the development continuum, from company formation to later-stage opportunities, and has funded more than 110 companies in the sector to date.
N.V. Nom, Investment and Development Agency for the Northern Netherlands, aims to make a contribution to the sustained improvement of the economic structure and employment in the Northern Netherlands.
BioVeda provides venture capital financing to companies in the life sciences with leading proprietary technologies and outstanding scientific and management talent. BioVeda positions itself as a crucial business and scientific bridge between companies in the East and West, linking finance and technology between two very diverse markets.
